Mabtas 500 mg Injection
$431.17
$111.75
Mabtas 500 mg Injection is a targeted monoclonal antibody designed to modulate the immune system effectively. This innovative treatment is primarily indicated for various hematologic malignancies, notably non-Hodgkin's lymphoma and chronic lymphocytic leukemia, providing hope for patients battling these serious conditions. By specifically targeting cancer cells, Mabtas helps to enhance the body’s natural immune response, promoting the destruction of abnormal cells while minimizing damage to healthy tissue. It is important to be aware that Mabtas may cause serious side effects, including infusion reactions and potential infections, necessitating careful monitoring by healthcare professionals. Patients should discuss their medical history and any concurrent medications with their doctor to ensure safe and effective use. As a vital option in cancer therapy, Mabtas is paving the way for improved outcomes and quality of life for individuals facing immune-related disorders. Always consult with your healthcare provider for personalized advice and to understand the full range of benefits and risks associated with this medication.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Mabtas 500 mg injection is commonly used in the treatment of non-Hodgkin lymphoma (NHL). This medication targets specific cells involved in the growth of cancer, helping to reduce tumor size and improve patient outcomes. It is often administered as part of a comprehensive treatment plan. Patients may receive Mabtas 500 mg injection in combination with other therapies for enhanced effectiveness.
• In the management of rheumatoid arthritis, Mabtas 500 mg injection serves to alleviate symptoms and slow disease progression. By modulating the immune response, it helps reduce inflammation and joint damage associated with this chronic condition. Patients experiencing severe symptoms may find relief through the use of Mabtas 500 mg injection as part of their treatment regimen. This can lead to improved quality of life and better functional ability.
• Mabtas 500 mg injection is also indicated for patients with chronic lymphocytic leukaemia, a type of blood cancer. It works by targeting the abnormal B-cells that proliferate in this condition, aiding in the reduction of cancerous cell counts. This targeted approach allows for a more effective management of the disease. Many patients benefit from Mabtas 500 mg injection as it can lead to prolonged remission periods.
• Additionally, Mabtas 500 mg injection is utilized in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis. These conditions involve inflammation of blood vessels, and Mabtas 500 mg injection helps to suppress this abnormal immune response. By doing so, it can help prevent further damage to organs and tissues. Patients may experience significant improvements in their symptoms with the use of Mabtas 500 mg injection.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Mabtas 500 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician. Rheumatoid arthritis: Mabtas 500 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician. Blood cancer (Chronic lymphocytic leukaemia): Leukaemia, also known as blood cancer, is a malignant neoplasm of the haematopoietic tissues that impairs the body's ability to combat infection. Mabtas 500 Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukaemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment. Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Mabtas 500 mg Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA. Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Mabtas 500 Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Mabtas 500 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Mabtas 500 mg Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Mabtas 500 mg. Please consult your doctor.
• Kidney: Mabtas 500 Injection is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Mabtas 500 mg Injection is likely to be safe to use while breast-feeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Mabtas 500 mg Injection is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Mabtas 500 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Mabtas 500 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.